Progress towards a public chemogenomic set for protein kinases and a call for contributions

David H. Drewry, Carrow I. Wells, David M. Andrews, Richard Angell, Hassan Al-Ali, Alison D. Axtman, Stephen J. Capuzzi, Jonathan M. Elkins, Peter Ettmayer, Mathias Frederiksen, Opher Gileadi, Nathanael Gray, Alice Hooper, Stefan Knapp, Stefan Laufer, Ulrich Luecking, Michael Michaelides, Susanne Müller, Eugene Muratov, R. Aldrin DennyKumar S. Saikatendu, Daniel K. Treiber, William J. Zuercher, Timothy M. Willson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.

Original languageEnglish (US)
Article numbere0181585
JournalPLoS One
Volume12
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

protein kinases
Protein Kinases
phosphotransferases (kinases)
Phosphotransferases
Drug Discovery
Complement System Proteins
complement
drugs
therapeutics
Molecules
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Drewry, D. H., Wells, C. I., Andrews, D. M., Angell, R., Al-Ali, H., Axtman, A. D., ... Willson, T. M. (2017). Progress towards a public chemogenomic set for protein kinases and a call for contributions. PLoS One, 12(8), [e0181585]. https://doi.org/10.1371/journal.pone.0181585

Progress towards a public chemogenomic set for protein kinases and a call for contributions. / Drewry, David H.; Wells, Carrow I.; Andrews, David M.; Angell, Richard; Al-Ali, Hassan; Axtman, Alison D.; Capuzzi, Stephen J.; Elkins, Jonathan M.; Ettmayer, Peter; Frederiksen, Mathias; Gileadi, Opher; Gray, Nathanael; Hooper, Alice; Knapp, Stefan; Laufer, Stefan; Luecking, Ulrich; Michaelides, Michael; Müller, Susanne; Muratov, Eugene; Denny, R. Aldrin; Saikatendu, Kumar S.; Treiber, Daniel K.; Zuercher, William J.; Willson, Timothy M.

In: PLoS One, Vol. 12, No. 8, e0181585, 01.08.2017.

Research output: Contribution to journalArticle

Drewry, DH, Wells, CI, Andrews, DM, Angell, R, Al-Ali, H, Axtman, AD, Capuzzi, SJ, Elkins, JM, Ettmayer, P, Frederiksen, M, Gileadi, O, Gray, N, Hooper, A, Knapp, S, Laufer, S, Luecking, U, Michaelides, M, Müller, S, Muratov, E, Denny, RA, Saikatendu, KS, Treiber, DK, Zuercher, WJ & Willson, TM 2017, 'Progress towards a public chemogenomic set for protein kinases and a call for contributions', PLoS One, vol. 12, no. 8, e0181585. https://doi.org/10.1371/journal.pone.0181585
Drewry, David H. ; Wells, Carrow I. ; Andrews, David M. ; Angell, Richard ; Al-Ali, Hassan ; Axtman, Alison D. ; Capuzzi, Stephen J. ; Elkins, Jonathan M. ; Ettmayer, Peter ; Frederiksen, Mathias ; Gileadi, Opher ; Gray, Nathanael ; Hooper, Alice ; Knapp, Stefan ; Laufer, Stefan ; Luecking, Ulrich ; Michaelides, Michael ; Müller, Susanne ; Muratov, Eugene ; Denny, R. Aldrin ; Saikatendu, Kumar S. ; Treiber, Daniel K. ; Zuercher, William J. ; Willson, Timothy M. / Progress towards a public chemogenomic set for protein kinases and a call for contributions. In: PLoS One. 2017 ; Vol. 12, No. 8.
@article{86d9ae29a05449e6ac248347642beb50,
title = "Progress towards a public chemogenomic set for protein kinases and a call for contributions",
abstract = "Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.",
author = "Drewry, {David H.} and Wells, {Carrow I.} and Andrews, {David M.} and Richard Angell and Hassan Al-Ali and Axtman, {Alison D.} and Capuzzi, {Stephen J.} and Elkins, {Jonathan M.} and Peter Ettmayer and Mathias Frederiksen and Opher Gileadi and Nathanael Gray and Alice Hooper and Stefan Knapp and Stefan Laufer and Ulrich Luecking and Michael Michaelides and Susanne M{\"u}ller and Eugene Muratov and Denny, {R. Aldrin} and Saikatendu, {Kumar S.} and Treiber, {Daniel K.} and Zuercher, {William J.} and Willson, {Timothy M.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1371/journal.pone.0181585",
language = "English (US)",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Progress towards a public chemogenomic set for protein kinases and a call for contributions

AU - Drewry, David H.

AU - Wells, Carrow I.

AU - Andrews, David M.

AU - Angell, Richard

AU - Al-Ali, Hassan

AU - Axtman, Alison D.

AU - Capuzzi, Stephen J.

AU - Elkins, Jonathan M.

AU - Ettmayer, Peter

AU - Frederiksen, Mathias

AU - Gileadi, Opher

AU - Gray, Nathanael

AU - Hooper, Alice

AU - Knapp, Stefan

AU - Laufer, Stefan

AU - Luecking, Ulrich

AU - Michaelides, Michael

AU - Müller, Susanne

AU - Muratov, Eugene

AU - Denny, R. Aldrin

AU - Saikatendu, Kumar S.

AU - Treiber, Daniel K.

AU - Zuercher, William J.

AU - Willson, Timothy M.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.

AB - Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.

UR - http://www.scopus.com/inward/record.url?scp=85026669220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026669220&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0181585

DO - 10.1371/journal.pone.0181585

M3 - Article

C2 - 28767711

AN - SCOPUS:85026669220

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0181585

ER -